Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects
Clinical trial NCT02927457 · COMPLETED
Trial details
- NCT number
- NCT02927457
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-13
- Primary completion
- 2018-06-12
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.